O'Connor-McCourt M - Search Results

1

Glycoproteomic comparison of clinical triple-negative and luminal breast tumors.

Hill JJ, Tremblay TL, Fauteux F, Li J, Wang E, Aguilar-Mahecha A, Basik M, O'Connor-McCourt M. Hill JJ, et al. J Proteome Res. 2015 Mar 6;14(3):1376-88. doi: 10.1021/pr500987r. Epub 2015 Feb 16. J Proteome Res. 2015. PMID: 25658377

2

Glycoproteomic analysis of two mouse mammary cell lines during transforming growth factor (TGF)-beta induced epithelial to mesenchymal transition.

Hill JJ, Tremblay TL, Cantin C, O'Connor-McCourt M, Kelly JF, Lenferink AE. Hill JJ, et al. Proteome Sci. 2009 Jan 8;7:2. doi: 10.1186/1477-5956-7-2. Proteome Sci. 2009. PMID: 19128513 Free PMC article.

3

Identification of vascular breast tumor markers by laser capture microdissection and label-free LC-MS.

Hill JJ, Tremblay TL, Pen A, Li J, Robotham AC, Lenferink AE, Wang E, O'Connor-McCourt M, Kelly JF. Hill JJ, et al. J Proteome Res. 2011 May 6;10(5):2479-93. doi: 10.1021/pr101267k. Epub 2011 Apr 1. J Proteome Res. 2011. PMID: 21401208

4

Computational selection of antibody-drug conjugate targets for breast cancer.

Fauteux F, Hill JJ, Jaramillo ML, Pan Y, Phan S, Famili F, O'Connor-McCourt M. Fauteux F, et al. Among authors: o connor mccourt m. Oncotarget. 2016 Jan 19;7(3):2555-71. doi: 10.18632/oncotarget.6679. Oncotarget. 2016. PMID: 26700623 Free PMC article.

5

Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.

Aguilar-Mahecha A, Cantin C, O'Connor-McCourt M, Nantel A, Basik M. Aguilar-Mahecha A, et al. Proteome Sci. 2009 Apr 6;7:15. doi: 10.1186/1477-5956-7-15. Proteome Sci. 2009. PMID: 19348683 Free PMC article.

6

A mass spectrometry-based plasma protein panel targeting the tumor microenvironment in patients with breast cancer.

Cohen A, Wang E, Chisholm KA, Kostyleva R, O'Connor-McCourt M, Pinto DM. Cohen A, et al. J Proteomics. 2013 Apr 9;81:135-47. doi: 10.1016/j.jprot.2012.11.004. Epub 2012 Nov 20. J Proteomics. 2013. PMID: 23174118

7

Identification of high-quality cancer prognostic markers and metastasis network modules.

Li J, Lenferink AE, Deng Y, Collins C, Cui Q, Purisima EO, O'Connor-McCourt MD, Wang E. Li J, et al. Nat Commun. 2010 Jul 13;1(4):34. doi: 10.1038/ncomms1033. Nat Commun. 2010. PMID: 20975711 Free PMC article.

8

Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets.

Zaman N, Li L, Jaramillo ML, Sun Z, Tibiche C, Banville M, Collins C, Trifiro M, Paliouras M, Nantel A, O'Connor-McCourt M, Wang E. Zaman N, et al. Cell Rep. 2013 Oct 17;5(1):216-23. doi: 10.1016/j.celrep.2013.08.028. Epub 2013 Sep 26. Cell Rep. 2013. PMID: 24075989 Free article.

9

Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.

Gao S, Tibiche C, Zou J, Zaman N, Trifiro M, O'Connor-McCourt M, Wang E. Gao S, et al. Among authors: o connor mccourt m. JAMA Oncol. 2016 Jan;2(1):37-45. doi: 10.1001/jamaoncol.2015.3413. JAMA Oncol. 2016. PMID: 26502222

10

Cancer systems biology: exploring cancer-associated genes on cellular networks.

Wang E, Lenferink A, O'Connor-McCourt M. Wang E, et al. Cell Mol Life Sci. 2007 Jul;64(14):1752-62. doi: 10.1007/s00018-007-7054-6. Cell Mol Life Sci. 2007. PMID: 17415519 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters